Rtw Investments, LP Uro Gen Pharma Ltd. Transaction History
Rtw Investments, LP
- $6.1 Billion
- Q1 2025
A detailed history of Rtw Investments, LP transactions in Uro Gen Pharma Ltd. stock. As of the latest transaction made, Rtw Investments, LP holds 3,834,794 shares of URGN stock, worth $15 Million. This represents 0.69% of its overall portfolio holdings.
Number of Shares
3,834,794
Previous 3,834,794
-0.0%
Holding current value
$15 Million
Previous $40.8 Million
3.85%
% of portfolio
0.69%
Previous 0.67%
Shares
6 transactions
Others Institutions Holding URGN
# of Institutions
142Shares Held
41.6MCall Options Held
91.4KPut Options Held
42.1K-
Ubs Asset Management Americas Inc Chicago, IL4.36MShares$17 Million0.01% of portfolio
-
Ra Capital Management, L.P. Boston, MA3.21MShares$12.5 Million0.74% of portfolio
-
Menora Mivtachim Holdings Ltd.2.3MShares$8.98 Million0.17% of portfolio
-
Black Rock Inc. New York, NY2.19MShares$8.56 Million0.0% of portfolio
-
Vestal Point Capital, LP New York, NY2.15MShares$8.4 Million1.7% of portfolio
About UroGen Pharma Ltd.
- Ticker URGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 22,740,500
- Market Cap $88.7M
- Description
- UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...